Ribavirin Articles & Analysis
1 news found
BIT225 is Biotron's lead antiviral, clinical stage, investigational, orally-dosed small molecule drug that has been evaluated in nine clinical trials involving healthy volunteers, patients with HIV-1 infection, patients co-infected with Hepatitis C virus ('HCV') and HIV-1 and patients with HCV (as monotherapy and in combination with pegylated interferon-alfa and ribavirin). ...